Cervical cancer rates are almost 90% lower in women vaccinated against HPV, a new study has found.
Women offered the vaccine between the ages of 12 and 13 were found to have cancer rates 87% lower than in previous generations, according to a study published in The Lancet.
Researchers also found a reduction of 62% in women vaccinated between ages 14 and 16.
The first generation of women, who were offered “catch-up” jabs aged between 16 and 18, were found to have a 34% reduction in cervical cancer rates.
Professor Peter Sasieni, from King’s College London and one of the authors of the paper, told Sky News some of the results were “almost too good to be true”.
Advertisement
“Everything is on target to be preventing essentially all cancers from HPV 16 and 18 in vaccinated women,” he said.
He said there was also “some cross-protection” for other cancers caused by the human papillomavirus and “some protection, although much less, to women of the same age who are not actually vaccinated”.
More from UK
He continued: “There is a lot of vaccine hesitancy going on these days.
“People who are opposed to these vaccines can no longer say this vaccine doesn’t prevent cancer because this makes it absolutely clear it is having a dramatic effect on cervical cancer incidents.”
“We need to think about the impact that will have,” he said.
“People don’t come in because they are revising, or they only come in for exams. So to get the same uptake of the vaccine will be challenging – as I am sure it has been challenging the last year and a half because of COVID.”
HPV vaccination has been introduced in 100 countries as part of efforts by the World Health Organisation (WHO) to eliminate cervical cancer.
It is a common sexually transmitted infection, with some types being linked to cervical cancer in women and head and neck cancer in men.
The English HPV vaccination programme was introduced in 2008, with vaccines given to women aged between 12 and 13 and “catch-up” jabs offered to older age groups up to the age of 18.
England initially used a bivalent vaccine, which protects against the two most common types of HPV, responsible for approximately 70% to 80% of all cervical cancers. Since September 2012, the quadrivalent vaccine Gardasil has been used instead.
The study looked at the population-based cancer registry data between January 2006 and June 2019 for seven cohorts of women, aged between 20 and 64.
During that time frame, 28,000 diagnoses of cervical cancer and 300,000 diagnoses of non-invasive cervical carcinoma (CIN3) in total were recorded in England.
In the three vaccinated cohorts, there were just 638 cases of cervical cancers and 18,662 cases of CIN3 compared to the non-vaccinated population.
Prof Sasieni said cases in young women were “very traumatic on everyone”.
“When talking to colleagues who treat women, they always remember the young ones and sometimes it is very aggressive and they can’t help that much,” he said.
One of the benefits of such an effective vaccine, he said, could mean women require less cervical screening, adding: “It doesn’t make sense to say you need to continue screening in the same way.”
But he said until the policy was changed, “the last thing we want is for women to think, I have been vaccinated so I don’t need to attend my screening – because that could have really serious consequences”.
The authors of the study did acknowledge some limitations – principally that cervical cancer diagnosis is rare in young women. Because the vaccinated populations are still young, the authors also stressed this means that it is still too early to assess the full impact of HPV immunisation on cervical cancer rates.
“Losing Gary, my soul mate, was beyond painful,” says Kathryn Croucher, whose husband died aged 42 in 2010.
“Every day was a struggle dealing with the knowledge he was HIV and Hepatitis C positive.”
“Mum always said she was given a death sentence,” recalls Ronan Fitzgerald. His mother, Jane, died aged 54 after being infected with Hepatitis C when she was 16. “It was a ticking time bomb.”
Please use Chrome browser for a more accessible video player
4:51
The faces of the infected blood scandal.
More than 30,000 Britons were infected with HIV and Hepatitis C after being given contaminated blood products in the 1970s and 1980s.
Around 3,000 people have died as a result of the scandal, while many more still live under the shadow of health problems, debilitating treatments and stigma. Now, the findings of a public inquiry, first announced in 2017, will finally be published.
These are 100 faces of infected blood victims that either they, or their families, have shared with Sky News.
Click the images to read their stories.
Sky News will have full coverage of the infected blood report on TV, online and on the Sky News app today.
Sky News would like to thank everyone who contributed to this project.
Julian Assange will be allowed to appeal against his extradition to the United States.
Two judges responded today to US assurances that Mr Assange will not face the death penalty – and can rely on the First Amendment right to free speech if he faced a trial for spying.
The WikiLeaks founder faces prosecution in the US over an alleged conspiracy to obtain and disclose national defence information after the publication of hundreds of thousands of leaked documents relating to the Afghanistan and Iraq wars.
Edward Fitzgerald KC, representing Assange, criticised the assurances of Joe Biden’s US administration at the hearing. He said: “Based on the principle of the separation of powers, the US court can and will apply US law, whatever the executive may say or do.”
He added most of the promises were “blatantly inadequate” – but they had accepted the promise about the death penalty.
In written submissions, the barrister said while the assurance over the death penalty was “an unambiguous executive promise”, the other assurance does not give “any reliable promise as to future action”.
The barrister added: “What needs to be conclusively removed is the risk that he will be prevented from relying on the first amendment on grounds of nationality.”
But James Lewis KC, representing the US government, insisted the “judicial branch of the United States will take due notice of this solemn assurance given by its government in the course of international relations”.
In written submissions, he said there is “no question” that Assange, if extradited, “will be entitled to the full panoply of due process trial rights, including the right to raise, and seek to rely upon, the first amendment as a defence”.
He later told the court: “The assurance does make it clear that he will not be discriminated against because of his nationality.
“He can and will be able to raise all those arguments and his nationality will not prejudice a fair trial.”
Today’s decision is the latest chapter in 13 years of legal battles and detentions for Australian-born Mr Assange.
Follow Sky News on WhatsApp
Keep up with all the latest news from the UK and around the world by following Sky News
The US authorities want to put Mr Assange on trial over 18 charges, nearly all under the Espionage Act.
They claim his actions with WikiLeaks were reckless, damaged national security, and endangered the lives of agents.
During a two-day hearing in February, lawyers for Mr Assange asked for permission to challenge a judge’s dismissal of the majority of his case to prevent his extradition.
In March, Dame Victoria Sharp and Mr Justice Johnson dismissed most of Mr Assange’s legal arguments – but said unless assurances were given by the US, he would be able to bring an appeal on three grounds.
These assurances are that Assange would be protected by and allowed to rely on the First Amendment – which protects freedom of speech in the US – that he is not “prejudiced at trial” due to his nationality, and that the death penalty is not imposed.
Supporters of Mr Assange have already been gathering outside the High Court to continue their calls for his release.
Mr Assange is currently being held in London’s high security Belmarsh prison.
Detective Inspector Lesley-Ann McGee said: “It was a warm, sunny day and there were lots of people out enjoying the weather in Saracen.
“I am asking them to get in touch with us with any information that could assist us in establishing the motive for this attack. If you saw, heard or know anything please contact us.
“I’m also asking people with dashcam or doorbell recording equipment to check for any footage that could assist our investigation.
“A family is mourning the loss of a loved one and it’s imperative we are able to answer how their loved one died.”